WHO researchers start trial on a new drug for river blindness.
Siva
Nayanah
N
D000349:Africa; D000969:Antinematodal Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use; D015827:Onchocerciasis, Ocular / Q000188:drug therapy*
D000969:Antinematodal Agents; D018942:Macrolides; C027837:moxidectin